Atlas Trials

Pulmonary sarcomatoid_MEDI4736+Treme

Clinical trial NCT03022500 · COMPLETED

Trial details

NCT number
NCT03022500
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC
Start date
2017-05-18
Primary completion
2018-02-28
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.